Aquatic Capital Management’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.89M | Buy |
106,899
+10,691
| +11% | +$389K | 0.08% | 298 |
|
|
2025
Q1 | $3.48M | Sell |
96,208
-6,363
| -6% | -$230K | 0.09% | 281 |
|
|
2024
Q4 | $4.32M | Buy |
102,571
+78,571
| +327% | +$3.31M | 0.12% | 224 |
|
|
2024
Q3 | $1.33M | Buy |
24,000
+5,000
| +26% | +$278K | 0.03% | 444 |
|
|
2024
Q2 | $781K | Sell |
19,000
-1,200
| -6% | -$49.3K | 0.03% | 448 |
|
|
2024
Q1 | $943K | Buy |
+20,200
| New | +$943K | 0.03% | 400 |
|
|
2023
Q4 | – | Sell |
-12,800
| Closed | -$456K | – | 1571 |
|
|
2023
Q3 | $456K | Buy |
12,800
+5,300
| +71% | +$189K | 0.02% | 504 |
|
|
2023
Q2 | $346K | Buy |
7,500
+2,300
| +44% | +$106K | 0.02% | 524 |
|
|
2023
Q1 | $209K | Buy |
+5,200
| New | +$209K | 0.01% | 576 |
|
|
2022
Q4 | – | Sell |
-2,500
| Closed | -$104K | – | 1742 |
|
|
2022
Q3 | $104K | Buy |
+2,500
| New | +$104K | 0.01% | 744 |
|